A5002172534- Organ Transplantation Techniques and Outcomes
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Transplantation: Methods and Outcomes
- Renal Transplantation Outcomes and Treatments
- Viral-associated cancers and disorders
- Hepatocellular Carcinoma Treatment and Prognosis
- Organ Donation and Transplantation
- Gallbladder and Bile Duct Disorders
- Liver Diseases and Immunity
- Hepatitis C virus research
- Pediatric Hepatobiliary Diseases and Treatments
- Bariatric Surgery and Outcomes
- Renal and Vascular Pathologies
- Hepatitis B Virus Studies
- Pancreatic and Hepatic Oncology Research
- Pulmonary Hypertension Research and Treatments
- Alcohol Consumption and Health Effects
- Cancer-related molecular mechanisms research
- Nutrition and Health in Aging
- Polyomavirus and related diseases
- Cardiac Ischemia and Reperfusion
- Cancer, Lipids, and Metabolism
- Neuroendocrine Tumor Research Advances
Mayo Clinic in Arizona
2016-2025
WinnMed
2016-2025
Mayo Clinic
2016-2025
Erasmus MC Cancer Institute
2023
University of Padua
2022
Erasmus MC
2022
John Wiley & Sons (United States)
2020
Hanover College
2020
Hudson Institute
2020
Moss Landing Marine Laboratories
2020
Marrero, Jorge A.; Kulik, Laura M.; Sirlin, Claude B.; Zhu, Andrew X.; Finn, Richard S.; Abecassis, Michael Roberts, Lewis R.; Heimbach, Julie K. Author Information
Potential conflict of interest: Laura M. Kulik is on the advisory board for Gilead, Bayer, Eisai, Salix, and Bristol‐Myers Squibb. Richard Finn consults Pfizer, Novartis, Merck, Claude B. Sirlin has received grants from Virtualscopics. Lewis R. Roberts Wako, Medscape, Axis; advises Tavec Bayer; speakers' bureau Onlive; Ariad, BTG, Gilead. Andrew Zhu Squibb, Sanofi, Bayer. The funding development this Practice Guideline was provided by American Association Study Liver Diseases. Guiding...
Singal, Amit G.; Llovet, Josep M.; Yarchoan, Mark; Mehta, Neil; Heimbach, Julie K.; Dawson, Laura A.; Jou, Janice H.; Kulik, Agopian, Vatche Marrero, Jorge Mendiratta-Lala, Mishal; Brown, Daniel B.; Rilling, William S.; Goyal, Lipika; Wei, Alice C.; Taddei, Tamar H. Author Information
Although mortality rates following liver transplantation (LT) are well described, there is a lack of detailed, prospective studies determining patterns and risk factors for long-term mortality. We analyzed the multicenter, prospectively obtained The National Institute Diabetes Digestive Kidney Diseases LT Database 798 transplant recipients from 1990 to 1994 (follow-up 2003). Overall, 327 died. Causes death >1 year: 28% hepatic, 22% malignancy, 11% cardiovascular, 9% infection, 6% renal...
Compare survival after neoadjuvant therapy and liver transplantation with resection for patients hilar CCA.
Two distinct pulmonary vascular disorders, hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) may occur as a consequence of hepatic parenchymal or abnormalities. HPS POPH have major clinical implications for liver transplantation. A European Respiratory Society Task Force on Pulmonary-Hepatic Disorders convened in 2002 to standardize the diagnosis guide management these disorders. These International Liver Transplant diagnostic guidelines are based that task force...
An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists met on 15 January 2014 to review current evidence the management hilar cholangiocarcinoma in order establish practice guidelines and agree statements. It was established that treatment patients with requires a coordinated, multidisciplinary approach optimize chances for both durable survival effective palliation. adequate diagnostic staging work-up includes high-quality cross-sectional...
Several factors are associated with increased hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT), but no reliable risk score has been established to determine the individual for HCC recurrence.We aimed develop and validate a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) patients meeting Milan criteria by imaging.Predictors were tested in development cohort 721 who underwent LT between 2002 2012 at 3 academic transplant centers (University...
The presence of an intrahepatic cholangiocarcinoma (iCCA) in a cirrhotic liver is contraindication for transplantation most centers worldwide. Recent investigations have shown that “very early” iCCA (single tumors ≤2 cm) may acceptable results after transplantation. This study further evaluates this finding larger international multicenter cohort. group was composed those patients who were transplanted hepatocellular carcinoma or decompensated cirrhosis and found to at explant pathology....
Obesity is increasingly common before and after liver transplantation (LT), yet optimal management remains unclear. Our aim was to analyze the effectiveness of a multidisciplinary protocol for obese patients requiring LT, including noninvasive pretransplant weight loss program, combined LT plus sleeve gastrectomy (SG) who failed lose prior LT. Since 2006, all referred with BMI > 35 were enrolled. There 37 achieved underwent alone, 7 SG. In those received gain seen in 21/34, post-LT diabetes...
The evolution of metabolic and cardiovascular disease (CVD) complications after liver transplantation (LT) is poorly characterized. We aim to illustrate the prevalence obesity syndrome (MS), define cumulative incidence CVD, characterize risk factors associated with these comorbidities LT. A retrospective review 455 consecutive LT recipients from 1999 2004 an 8‐ 12‐year follow‐up was performed. Obesity increased 23.8% (4 months) 40.8% (3 years) Increase in body mass index predicted MS at 1...
Patients with unresectable, stage I and II perihilar cholangiocarcinoma were treated neoadjuvant external beam irradiation, brachytherapy, 5-fluorouracil and/or oral capecitabine prior to liver transplantation. Fifty-six patients underwent treatment between 1993 2003. Four died 4 had disease progression completion of therapy. Forty-eight operative staging 14 findings precluding Twenty-eight transplantation 6 are awaiting Three from perioperative complications, developed recurrent 22 63...